Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 53% ± 18% | |
microglial cell | 12 studies | 34% ± 13% | |
GABAergic neuron | 11 studies | 54% ± 26% | |
glutamatergic neuron | 11 studies | 65% ± 23% | |
endothelial cell | 9 studies | 30% ± 14% | |
fibroblast | 7 studies | 28% ± 8% | |
macrophage | 7 studies | 39% ± 15% | |
retina horizontal cell | 6 studies | 48% ± 20% | |
myeloid cell | 5 studies | 23% ± 4% | |
pericyte | 5 studies | 20% ± 3% | |
ciliated cell | 5 studies | 30% ± 12% | |
type II pneumocyte | 5 studies | 27% ± 4% | |
neuron | 4 studies | 42% ± 9% | |
cardiac muscle cell | 4 studies | 26% ± 9% | |
epithelial cell | 4 studies | 31% ± 17% | |
monocyte | 4 studies | 18% ± 2% | |
interneuron | 4 studies | 72% ± 22% | |
GABAergic interneuron | 3 studies | 58% ± 20% | |
adipocyte | 3 studies | 24% ± 4% | |
retinal ganglion cell | 3 studies | 30% ± 12% | |
lymphocyte | 3 studies | 17% ± 2% | |
goblet cell | 3 studies | 41% ± 30% | |
smooth muscle cell | 3 studies | 19% ± 3% | |
granule cell | 3 studies | 36% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 2214.96 | 2567 / 2642 | 96% | 13.61 | 678 / 705 |
kidney | 99% | 640.12 | 88 / 89 | 94% | 12.02 | 843 / 901 |
pancreas | 99% | 645.76 | 326 / 328 | 89% | 6.12 | 159 / 178 |
adrenal gland | 100% | 1429.48 | 258 / 258 | 87% | 8.29 | 201 / 230 |
intestine | 100% | 1231.38 | 965 / 966 | 86% | 4.60 | 451 / 527 |
stomach | 93% | 460.63 | 335 / 359 | 90% | 5.26 | 256 / 286 |
skin | 97% | 611.43 | 1763 / 1809 | 82% | 5.69 | 386 / 472 |
lung | 99% | 723.34 | 573 / 578 | 80% | 4.67 | 920 / 1155 |
esophagus | 96% | 884.88 | 1380 / 1445 | 81% | 5.48 | 148 / 183 |
thymus | 99% | 512.62 | 644 / 653 | 74% | 3.73 | 447 / 605 |
breast | 100% | 816.96 | 459 / 459 | 72% | 3.72 | 801 / 1118 |
prostate | 96% | 553.77 | 234 / 245 | 74% | 2.82 | 369 / 502 |
liver | 97% | 535.57 | 220 / 226 | 59% | 2.77 | 238 / 406 |
uterus | 100% | 969.68 | 170 / 170 | 49% | 2.15 | 225 / 459 |
bladder | 100% | 1036.38 | 21 / 21 | 49% | 2.21 | 247 / 504 |
ovary | 98% | 628.28 | 177 / 180 | 17% | 0.49 | 74 / 430 |
adipose | 100% | 924.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 921.09 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 709.92 | 806 / 861 | 0% | 0 | 0 / 0 |
spleen | 93% | 323.50 | 223 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 49% | 2.15 | 39 / 80 |
lymph node | 0% | 0 | 0 / 0 | 48% | 2.70 | 14 / 29 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.48 | 16 / 45 |
peripheral blood | 20% | 98.52 | 187 / 929 | 0% | 0 | 0 / 0 |
muscle | 16% | 56.81 | 130 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015798 | Biological process | myo-inositol transport |
GO_0055085 | Biological process | transmembrane transport |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0097450 | Cellular component | astrocyte end-foot |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0071944 | Cellular component | cell periphery |
GO_0030426 | Cellular component | growth cone |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0044297 | Cellular component | cell body |
GO_0031090 | Cellular component | organelle membrane |
GO_0005366 | Molecular function | myo-inositol:proton symporter activity |
GO_0002020 | Molecular function | protease binding |
GO_0051117 | Molecular function | ATPase binding |
GO_0005365 | Molecular function | myo-inositol transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC2A13 |
Protein name | SLC2A13 protein Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13) Solute carrier family 2 member 13 |
Synonyms | |
Description | FUNCTION: H(+)-myo-inositol cotransporter . Can also transport related stereoisomers . . |
Accessions | ENST00000280871.9 Q86X07 ENST00000380858.1 E9PE47 Q96QE2 |